| CFAEX | VBTIX | CFAEX / VBTIX | |
| Total Expense Ratio | 0.81 | 0.03 | 3,240% |
| Annual Report Gross Expense Ratio | 0.81 | 0.03 | 3,240% |
| Fund Existence | 24 years | 31 years | - |
| Gain YTD | -0.536 | -1.740 | 31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 101B | 394B | 26% |
| Annual Yield % from dividends | 3.90 | 3.99 | 98% |
| Returns for 1 year | 3.85 | 0.31 | 1,227% |
| Returns for 3 years | 10.34 | 0.10 | 9,919% |
| Returns for 5 years | -2.30 | -14.55 | 16% |
| Returns for 10 years | 10.50 | -11.32 | -93% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DRES | 30.53 | -0.32 | -1.05% |
| GMO Domestic Resilience ETF | |||
| WEEI | 23.76 | -0.37 | -1.52% |
| Westwood Salient Enhanced Engy Inc ETF | |||
| BIB | 80.27 | -2.81 | -3.38% |
| ProShares Ultra Nasdaq Biotechnology | |||
| AAAU | 42.57 | -1.61 | -3.64% |
| Goldman Sachs Physical Gold ETF | |||
| NUEM | 39.95 | -1.93 | -4.61% |
| Nuveen ESG Emerging Markets Equity ETF | |||